Teva Pharmaceutical Industries Ltd. (TEVA) said that the U.S. Food and Drug Administration or FDA has approved QVAR RediHaler (beclomethasone dipropionate HFA) inhalation aerosol, a breath-actuated inhaler for the maintenance treatment of asthma as a prophylactic therapy in patients 4 years of age and older.
from RTT - Biotech http://ift.tt/2wmdmMm
via IFTTT
No comments:
Post a Comment